1. Home
  2. CVM

as of 12-05-2025 2:33pm EST

$6.36
+$0.07
+1.10%
Stocks Health Care Biotechnology: Biological Products (No Diagnostic Substances) Nasdaq

CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development of the treatment of cancer and other diseases using the immune system. The Company's core capabilities include drug discovery, research, development, and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.

Chart Type:
Time Range:
Founded: 1983 Country:
United States
United States
Employees: N/A City: VIENNA
Market Cap: 53.1M IPO Year: 1987
Target Price: N/A AVG Volume (30 days): 61.2K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -9.08 EPS Growth: N/A
52 Week Low/High: $1.98 - $32.70 Next Earning Date: 01-12-2026
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

AI-Powered CVM Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 2 days ago

AI Recommendation

hold
Model Accuracy: 76.35%
76.35%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Stock Insider Trading Activity of Cel-Sci Corporation (CVM)

KERSTEN GEERT R

Chief Executive Officer

Buy
CVM Dec 4, 2025

Avg Cost/Share

$5.96

Shares

8,389

Total Value

$49,998.44

Owned After

81,794

SEC Form 4

Share on Social Networks: